Frail elderly patients with relapsed-refractory multiple myeloma: efficacy and toxicity profile of the combination of bortezomib, high-dose dexamethasone, and low-dose oral cyclophosphamide

Giuseppe MeleClinical Division of Hematology and BMT Unit, ‘Antonio Perrino’ Hospital, Brindisi, ItalyCorrespondence[email protected]

Angela GiannottaClinical Division of Hematology and BMT Unit, ‘Antonio Perrino’ Hospital, Brindisi, Italy

Salvatore PinnaClinical Division of Hematology and BMT Unit, ‘Antonio Perrino’ Hospital, Brindisi, Italy

Giacomo LosetoClinical Division of Hematology and BMT Unit, ‘Antonio Perrino’ Hospital, Brindisi, Italy

Maria Rosaria CoppiClinical Division of Hematology and BMT Unit, ‘Antonio Perrino’ Hospital, Brindisi, Italy

Claudio Maurizio BroccaClinical Division of Hematology and BMT Unit, ‘Antonio Perrino’ Hospital, Brindisi, Italy

Angela MelpignanoClinical Division of Hematology and BMT Unit, ‘Antonio Perrino’ Hospital, Brindisi, Italy

Giovanni QuartaClinical Division of Hematology and BMT Unit, ‘Antonio Perrino’ Hospital, Brindisi, Italy

show all

Click to increase image sizeClick to decrease image size

Acknowledgements

We thank Mario Negro for technical assistance.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Frail elderly patients with relapsed-refractory multiple myeloma: efficacy and toxicity profile of the combination of bortezomib, high-dose dexamethasone, and low-dose oral cyclophosphamide

Information for

Open access

Opportunities

Help and information

Frail elderly patients with relapsed-refractory multiple myeloma: efficacy and toxicity profile of the combination of bortezomib, high-dose dexamethasone, and low-dose oral cyclophosphamide

Acknowledgements

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature